¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"isoniazid polyneuropathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® isoniazid(INH) ÇÑ±Û À̼ҴϾÆÁöÆ®
¼³¸í   
  Ç×°áÇÙÁ¦. °áÇÙ±ÕÀÇ ¼¼Æ÷º® ÇÕ¼ºÀ» ¹æÇØÇϴ ÀÛ¿ëÀ» ÇÑ´Ù. ´Ù¸¥ Ç×°áÇÙÁ¦¿Í ÇÔ²² »ç¿ëÇϸç ÀϹÝÀûÀ¸·Î 12~24°³¿ù Á¤µµ »ç¿ëÇÑ´Ù. ºÎÀÛ¿ëÀ¸·Î´Â ¹ß¿­, ¹ßÁø, °£Àå¾Ö, ºóÇ÷, È¯°¢, ½Ä¿åºÎÁø, º¹ÅëÀÌ ÀÖÀ» ¼ö ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • isoniazid
    À̼ҴϾÆÁöµå
  • polyneuropathy
    ¿©·¯½Å°æº´(Áõ), ´Ù¹ß½Å°æº´(Áõ)
  • paraneoplastic polyneuropathy
    ½Å»ý¹°µþ¸²¿©·¯½Å°æº´(Áõ), ½Å»ý¹°µþ¸²´Ù¹ß½Å°æº´(Áõ)
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • isoniazid
    À̼ҴϾÆÁöµå
  • polyneuropathy neuropathy
    ½Å»ý¹°µþ¸²¿©·¯½Å°æº´Áõ, ½Å»ý¹°µþ¸²´Ù¹ß½Å°æº´Áõ
  • polyneuropathy
    ¿©·¯½Å°æº´Áõ, ´Ù¹ß½Å°æº´Áõ
  • paraneoplastic polyneuropathy
    ½Å»ý¹°µþ¸²¿©·¯½Å°æº´Áõ, Á¾¾çµþ¸²´Ù¹ß½Å°æº´Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polyneuropathy
    ´Ù¹ß½Å°æº´Áõ, ¿©·¯½Å°æº´Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arsenical polyneuropathy
    ºñ¼Ò(¼º) ´Ù¹ß¼º ½Å°æº´Áõ.
  • polyneuropathy
    ´Ù¹ß½Å°æº´Áõ.
  • polyneuropathy
    ´Ù¹ß½Å°æº´Áõ(ÒýÛ¡ãêÌèÜ»ñø)
  • porphyric polyneuropathy
    Æ÷¸£ÇǸ°¼º ´Ù¹ß½Å°æº´Áõ.
  • porphyric polyneuropathy
    Æ÷¸£ÇǸ°¼º ´Ù¹ß½Å°æº´Áõ(¡­àõ ÒýÛ¡ãêÌèÜ»ñø)
  • relapsing polyneuropathy
    Àç¹ß¼º ´Ù¹ß½Å°æº´Áõ(¡­ÒýÛ¡ãêÌèÜ»ñø).
  • relapsing polyneuropathy
    Àç¹ß¼º ´Ù¹ß½Å°æº´Áõ(¡­ÒýÛ¡ãêÌèÜ»ñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alcoholic polyneuropathy
    ¾ËÄڿüº ´Ù¹ß (¼º)½Å°æº´Áõ(ÒýÛ¡àõãêÌèÜ»ñø).
  • arsenical polyneuropathy
    ºñ¼Ò(¼º) ´Ù¹ß¼º ½Å°æº´Áõ.
  • diphtheritic polyneuropathy
    µðÇÁÅ׸®¾Æ¼º ´Ù¹ß½Å°æº´Áõ(¡­ÒýÛ¡ãêÌèÜ»ñø).
  • familial amyloid polyneuropathy
    °¡Á·¼º ¾Æ¹Ð·ÎÀÌµå ´Ù¹ß½Å°æº´Áõ
  • familial amyloidotic polyneuropathy
    °¡Á·Àû ¾Æ¹Ð·ÎÀÌµå ´Ù¹ß½Å°æº´Áõ.
  • familial amyloidotic polyneuropathy
    °¡Á·Àû ¾Æ¹Ð·ÎÀÌµå ´Ù¹ß½Å°æº´Áõ
  • myelomatous polyneuropathy
    °ñ¼öÁ¾¼º ´Ù¹ß½Å°æº´Áõ(¡­ðþàõÒýÛ¡ãêÌèÜ»ñø).
  • myelomatous polyneuropathy
    °ñ¼öÁ¾¼º ´Ù¹ß½Å°æº´Áõ(¡­ðþàõÒýÛ¡ãêÌèÜ»ñø)
  • nutritional polyneuropathy
    ¿µ¾ç¼º ´Ù¹ß½Å°æº´Áõ.
  • polyneuropathy
    ´Ù¹ß½Å°æº´Áõ.
  • polyneuropathy
    ´Ù¹ß½Å°æº´Áõ(ÒýÛ¡ãêÌèÜ»ñø)
  • porphyric polyneuropathy
    Æ÷¸£ÇǸ°¼º ´Ù¹ß½Å°æº´Áõ.
  • porphyric polyneuropathy
    Æ÷¸£ÇǸ°¼º ´Ù¹ß½Å°æº´Áõ(¡­àõ ÒýÛ¡ãêÌèÜ»ñø)
  • relapsing polyneuropathy
    Àç¹ß¼º ´Ù¹ß½Å°æº´Áõ(¡­ÒýÛ¡ãêÌèÜ»ñø).
  • relapsing polyneuropathy
    Àç¹ß¼º ´Ù¹ß½Å°æº´Áõ(¡­ÒýÛ¡ãêÌèÜ»ñø)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • isoniazid
    ¾ÆÀ̼ҳªÀ̾ÆÁöµå
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DSPN distal sensory polyneuropathy; distal symmetrical polyneuropathy
INH Isoniazid
INH inhalation; isoniazid; isonicotinic acid hydrazide
FAP Familial Amyloid Polyneuropathy
GBS   1) Guillain-Barr Syndrome
    = PIP; Post-Infectious Polyneuropat...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
INH Isoniazid
isoniazid Isonicotinic acid hydrazide
AIDP Acute inflammatory demyelinating polyneuropathy
CIDP Chronic Inflammatory Demyelinating Polyneuropathy
CIP Critical illness polyneuropathy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • isoniazid : 1. 4-pyridinecarboxylic acid hydrazide. ¹«»ö ¶Ç´Â ¹é»öÀÇ °áÁ¤À̳ª ºÐ¸». °áÇÙ Ä¡·á¿¡ »ç¿ëµÇ¸ç, ³»º¹ ¶Ç´Â ±ÙÀ°¿¡ ÁÖ»çÇÑ´Ù. 2. °áÇÙ±Õ¿¡ ´ëÇÑ È­ÇÐ ¿ä¹ý ¾àÀÇ Çϳª·Î 1Â÷ Ç×°áÇÙÁ¦·Î ¾²ÀδÙ. Àå±â Åõ¿©°¡ µÇ¹Ç·Î ºÎÀÛ¿ë Æ¯È÷ ½Å°æ, ¼ÒÈ­±â Àå¾Ö¿¡ ÁÖÀǸ¦ ¿ä
    µ¿Á¾ µ¶ ¿ä¹ý
    ÁúȯÀÇ »ý»ê¹° ¶Ç´Â ÀÌȯ Àå±â·ÎºÎÅÍ ÃßÃâÇÏ¿© ¸¸µç ¹°Áú·Î ÁúȯÀ» Ä¡·áÇÏ´Â ¹æ¹ý.
  • familial amyloid polyneuropathy
    °¡Á·¼º ¾Æ¹Ð·ÎÀÌµå ´Ù¹ß ½Å°æº´Áõ
  • polyneuropathy
    ´Ù¹ß¼º ½Å°æ º´º¯, ´Ù¹ß¼º ½Å°æº´Áõ, ´Ù¹ß ½Å°æº´Áõ
    ¿©·¯ °³ÀÇ ½Å°æÀ» ÀÌȯÇÏ´Â ÁúȯÀ¸·Î¼­ º¸Åë ¾çÃø¼ºÀÌ°í ¹Ì¸¸¼ºÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
isoniazid polyneuropathy An axonal loss polyneuropathy seen in some patients treated with isoniazid.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
isoniazid <drug> An orally administered drug used to eliminate tuberculosis infection in people without active disease. INH is also administered in combination with other drugs to treat active tuberculosis. Side effects include liver impairment and peripheral neuropathy (see).
(09 Oct 1997)
isoniazid acetyltransferase <enzyme> Used to study acetylator phenotype for metabolism of hydrazines and arylamine carcinogen
Registry number: EC 2.3.1.-
Synonym: isoniazide n-acetyltransferase, hydrazine n-acetyltransferase
(26 Jun 1999)
isoniazid neuropathy An axonal form of neuropathy seen in some patients treated with isoniazid.
(05 Mar 2000)
acute demyelinating polyneuropathy <neurology> A neurologic condition.
Synonym: Guillain-Barre syndrome.
Origin: Gr. Pathos = disease
(27 Sep 1997)
acute inflammatory polyneuropathy <neurology, syndrome> Acute infective polyneuritis that results in a form of peripheral neuropathy with temporary loss of movement and sensation due to inflammation of multiple nerves and loss of myelin.
The exact cause is unknown but has been associated with an abnormal immune response to viral infection, particularly cytomegalovirus infection, in which there is cell-mediated immunity to a component of myelin. The disease may be autoimmune in origin and complete recovery can take up to six months.
Synonym: Guillain-Barre syndrome
(12 Jul 2000)
alcoholic polyneuropathy <neurology> A disorder that occurs secondary to the damage to nerve cells from habitual alcohol abuse.
The effects of alcoholic polyneuropathy may be due in part to the direct toxic effect alcohol has on nervous tissue in combination with specific nutritional deficiencies (for example B1 or thiamin deficiency and B12 deficiency).
Common symptoms include sensory changes, numbness, tingling, muscle weakness, muscle cramps, heat intolerance, impotence, difficulty urinating, swallowing difficulty, speech impairment, diarrhoea and constipation.
Origin: Gr. Pathos = disease
(27 Sep 1997)
arsenical polyneuropathy An axon loss polyneuropathy that results from subacute or chronic arsenic poisoning; almost always preceded by gastrointestinal symptoms; one of the heavy metal neuropathies.
(05 Mar 2000)
axonal polyneuropathy A type of polyneuropathy in which axon degeneration is the sole/predominant feature; many aetiologies, particularly toxic and metabolic; on nerve conduction studies, affects amplitudes of the responses, but does not cause conduction slowing or block.
Synonym: axonal polyneuropathy.
(05 Mar 2000)
axon loss polyneuropathy A type of polyneuropathy in which axon degeneration is the sole/predominant feature; many aetiologies, particularly toxic and metabolic; on nerve conduction studies, affects amplitudes of the responses, but does not cause conduction slowing or block.
Synonym: axonal polyneuropathy.
(05 Mar 2000)
buckthorn polyneuropathy Ascending polyneuropathy resulting from ingestion of the fruit of Karwinskia humboldtiana.
(05 Mar 2000)
chronic inflammatory demyelinating polyneuropathy An uncommon, acquired, demyelinating sensorimotor polyneuropathy, clinically characterised by insidious onset, and slow evolution, (either steady progression or stepwise), and chronic course; symmetrical weakness is a predominant symptom, often involving proximal leg muscles, accompanied by paresthesias, but not pain; CSF examination shows elevated protein, while electrodiagnostic studies reveal evidence of a demyelinating process, primarily conduction slowing rather than block; sometimes responds to prednisone.
(05 Mar 2000)
chronic inflammatory polyneuropathy <neurology, pathology> A disorder that involves the slow progressive (or recurrent) inflammation of multiple nerves. Loss of movement and sensation are common findings. The exact cause is related to an abnormal immune response.
The acute form of this illness is known as Guillain-Barre syndrome. Treatment often includes systemic corticosteroids or chemotherapeutic agents to suppress the immune system. Prognosis is variable.
Origin: Gr. Pathos = disease
(27 Sep 1997)
polyneuropathy <neurology> A disease process involving a number of peripheral nerves.
Origin: Gr. Pathos = disease
(14 Oct 1997)
critical illness polyneuropathy A diffuse axon loss sensorimotor polyneuropathy seen in severely ill patients, usually in the intensive care unit; most patients have been on multiple drugs, and cannot be weaned from ventilatory support; electrodiagnostic studies show evidence of an axon loss polyneuropathy, predominantly motor; of unknown aetiology.
(05 Mar 2000)
progressive hypertrophic polyneuropathy A familial type of demyelinating sensorimotor polyneuropathy that begins in early childhood and is slowly progressive; clinically characterised by foot pain and paresthesias, followed by symmetrical weakness and wasting of the distal limbs; one of the causes of stork legs; patients are wheelchair bound at an early age; peripheral nerves are palpably enlarged and non-tender; pathologically, onion bulb formation is seen in the nerves: whorls of overlapping, intertwined Schwann cell processes that encircle bare axons; usually autosomal recessive inheritance.
Synonym: Dejerine's disease, progressive hypertrophic polyneuropathy.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • isoniazid
    À̼ҴϾÆÁöµå;À̼ҴÏÄÚÆ¾»ê ÇÏÀ̵å¶óÁöµå(Ç×°áÇÙÁ¦)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á